Patents Assigned to Theranos, Inc.
  • Patent number: 9250229
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Grant
    Filed: February 18, 2013
    Date of Patent: February 2, 2016
    Assignee: Theranos, Inc.
    Inventor: Elizabeth A. Holmes
  • Patent number: 9182388
    Abstract: The present invention provides methods of calibrating a fluidic device useful for detecting an analyte of interest in a bodily fluid. The invention also provides methods for assessing the reliability of an assay for an analyte in a bodily fluid with the use of a fluidic device. Another aspect of the invention is a method for performing a trend analysis on the concentration of an analyte in a subject using a fluidic device.
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: November 10, 2015
    Assignee: Theranos, Inc.
    Inventors: Ian Gibbons, Chengwang Wang, Shaunak Roy, Elizabeth A. Holmes
  • Patent number: 9176126
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: May 6, 2014
    Date of Patent: November 3, 2015
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, Ian Gibbons, Shize Daniel Qi, Edmond Ku, Chris Todd, Melissa Takahashi, Bruce Johnson, Jeff Fenton, Keith Moravick, Uwe Springborn, Anthony Delacruz
  • Publication number: 20150299777
    Abstract: Systems, methods, and devices for detecting infections in a clinical sample are provided. Small-volume clinical samples obtained at a point-of-service (POS) location and may be tested at the POS location for multiple markers for multiple diseases, including upper and lower respiratory diseases. Samples may be tested for cytokines, or for inflammation indicators. Dilution of samples, or levels of detection, may be determined by the condition or past history of a subject. Test results may be obtained within a short amount of time after sample placement in a testing device, or within a short amount of time after being obtained from the subject. A prescription for treatment of a detected disorder may be provided, and may be filled, at the POS location. A bill may be automatically generated for the testing, or for the prescription, may be automatically sent to an insurance provider, and payment may be automatically obtained.
    Type: Application
    Filed: January 23, 2015
    Publication date: October 22, 2015
    Applicant: THERANOS, INC.
    Inventors: Pranav Patel, Scott Tabakman, Kamila Belhocine, Aaron Richardson, Josephine Lee, Clarissa Lui
  • Patent number: 9131884
    Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: September 15, 2015
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang
  • Patent number: 9128015
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: September 8, 2015
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, John Kent Frankovich
  • Patent number: 9121851
    Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: September 1, 2015
    Assignee: Theranos, Inc.
    Inventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
  • Patent number: 9075046
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides fluidic systems having a plurality of reaction sites surrounded by optical barriers to reduce the amount of optical cross-talk between signals detected from various reaction sites. The invention also provides a method of manufacturing fluidic systems and methods of using the systems.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: July 7, 2015
    Assignee: Theranos, Inc.
    Inventors: Timothy M. Kemp, Chris Todd, Ron Oral, Shulin Zeng, John Howard, Jeff Fenton
  • Patent number: D733314
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: June 30, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui
  • Patent number: D733315
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: June 30, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui
  • Patent number: D733316
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: June 30, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui
  • Patent number: D733317
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: June 30, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui
  • Patent number: D733318
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: June 30, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui
  • Patent number: D743024
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: November 10, 2015
    Assignee: Theranos, Inc.
    Inventor: Patricia McHale
  • Patent number: D744089
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: November 24, 2015
    Assignee: Theranos, Inc.
    Inventor: Patricia McHale
  • Patent number: D745662
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: December 15, 2015
    Assignee: Theranos, Inc.
    Inventor: Michael Chen
  • Patent number: D745663
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: December 15, 2015
    Assignee: Theranos, Inc.
    Inventor: Michael Chen
  • Patent number: D746976
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: January 5, 2016
    Assignee: Theranos, Inc.
    Inventors: Michael Chen, Patricia McHale
  • Patent number: D748279
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: January 26, 2016
    Assignee: Theranos, Inc.
    Inventor: Patricia McHale
  • Patent number: D748280
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: January 26, 2016
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui